The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy

Ethical guidelines for investigations of experimental pain in conscious animals.

Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762 · see citing works

Cellular and Molecular Mechanisms of Pain

Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain

Yoon, C., Wook, Y. Y., Na, H. S., Ho, K. S., & Mo, C. J. (1994) · Pain · doi:10.1016/0304-3959(94)90023-x · Cited by 868 · see citing works

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793 · see citing works

Clinical toxicities encountered with paclitaxel (Taxol).

Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692 · see citing works

The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review

Petrenko, A. B., Yamakura, T., Baba, H., & Shimoji, K. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000081061.12235.55 · Cited by 672 · see citing works

Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies

Wolf, S. L., Barton, D. L., Kottschade, L. A., Grothey, A. F., & Loprinzi, C. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.018 · Cited by 632 · see citing works

Chemokines, neuronal–glial interactions, and central processing of neuropathic pain

Gao, Y., & Ji, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.002 · Cited by 629 · see citing works

Chemotherapy‐induced neuropathy

Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613 · see citing works

HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor

Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 574 · see citing works

Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction

Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 536 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

Polomano, R. C., Mannes, A. J., Clark, U. S., & Bennett, G. J. (2001) · Pain · doi:10.1016/s0304-3959(01)00363-3 · Cited by 476 · see citing works

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476 · see citing works

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · see citing works

Cannabinoid CB ₂ receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423 · see citing works

Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons

Kajander, K. C., & Bennett, G. J. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.68.3.734 · Cited by 372 · see citing works

Peripheral sensory neuropathy and cisplatin chemotherapy

Roelofs, R. I., Hrushesky, W. J. M., Rogin, J. B., & Rosenberg, L. (1984) · Neurology · doi:10.1212/wnl.34.7.934 · Cited by 369 · see citing works

Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy

Jaggi, A. S., & Singh, N. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.019 · Cited by 357 · see citing works

Taxol produces a predominantly sensory neuropathy

Lipton, R. B., Apfel, S. C., Dutcher, J. P., Rosenberg, R., Kaplan, J., Berger, A., Einzig, A. I., Wiernik, P. H., & Schaumburg, H. H. (1989) · Neurology · doi:10.1212/wnl.39.3.368 · Cited by 317 · see citing works

Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells

Siau, C., Xiao, W. H., & BENNETT, G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.007 · Cited by 302 · see citing works

Degeneration of Myelinated Efferent Fibers Induces Spontaneous Activity in Uninjured C-Fiber Afferents

Wu, G., Ringkamp, M., Murinson, B. B., Pogatzki, E. M., Hartke, T. V., Weerahandi, H. M., Campbell, J. N., Griffin, J. W., & Meyer, R. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07746.2002 · Cited by 279 · see citing works

Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy

Zheng, H., Xiao, W. H., & Bennett, G. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.016 · Cited by 273 · see citing works

Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment

Pachman, D. R., Barton, D. L., Watson, J. C., & Loprinzi, C. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.115 · Cited by 269 · see citing works

Interaction of Transient Receptor Potential Vanilloid 4, Integrin, and Src Tyrosine Kinase in Mechanical Hyperalgesia

Alessandri‐Haber, N., Dina, O. A., Joseph, E. K., Reichling, D. B., & Levine, J. D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4497-07.2008 · Cited by 226 · see citing works

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 217 · see citing works

CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic pain

Cao, L., & DeLeo, J. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737485 · Cited by 212 · see citing works

Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy

Zhang, H.-J., Yoon, S.-Y., Zhang, H.-M., & Dougherty, P. (2012) · Journal of Pain · doi:10.1016/j.jpain.2011.12.002 · Cited by 211 · see citing works

Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy

Melli, G., Taiana, M. M., Camozzi, F., Triolo, D., Podini, P., Quattrini, A., Taroni, F., & Lauria, G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.013 · Cited by 202 · see citing works

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen

Goodnough, L. T., Saito, H., Manni, A., Jones, P. K., & Pearson, O. H. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7 · Cited by 200 · see citing works

Transient Receptor Potential Vanilloid 1 is Essential for Cisplatin-Induced Heat Hyperalgesia in Mice

Ta, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193 · see citing works

Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine

Xiao, W. H., & Bennett, G. J. (2007) · Pain · doi:10.1016/j.pain.2007.06.001 · Cited by 174 · see citing works

Role of protein kinase Cϵ and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat

Dina, O. A., Chen, X., Reichling, D. B., & Levine, J. D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00425-0 · Cited by 167 · see citing works

Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons

Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166 · see citing works

An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections

Authier, N. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00003-7 · Cited by 165 · see citing works

Cannabinoid CB₂ receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160 · see citing works

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

Sagar, D. R., Kelly, S., Millns, P. J., O'Shaughnessey, C. T., Kendall, D. A., & Chapman, V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04206.x · Cited by 154 · see citing works

Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat

Xiao, W. H., Zheng, H., Zheng, F. Y., Nuydens, R., Meert, T. F., & Bennett, G. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.010 · Cited by 154 · see citing works

CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy

Bhangoo, S. K., Ren, D., Miller, R. J., Chan, D., Ripsch, M. S., Weiß, C., McGinnis, C., & White, F. A. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.12.003 · Cited by 150 · see citing works

Activation of cannabinoid CB₁ and CB₂ receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

Rahn, E. J., Makriyannis, A., & Hohmann, A. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707333 · Cited by 146 · see citing works

Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy

Khasabova, I. A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0403-12.2012 · Cited by 129 · see citing works

Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies

Authier, N., Balayssac, D., Marchand, F., Ling, B., Zangarelli‌, A., Descoeur, J., Coudoré, F., Bourinet, E., & Eschalier, A. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.003 · Cited by 120 · see citing works

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120 · see citing works

Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat

Tanner, K. D., Reichling, D. B., & Levine, J. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06480.1998 · Cited by 119 · see citing works

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., & Hohmann, A. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141994 · Cited by 116 · see citing works

CXC Chemokine Receptor 4 Expression and Function in Human Astroglioma Cells

Oh, J., Drabik, K., Kutsch, O., Choi, C., Tousson, A., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2695 · Cited by 114 · see citing works

Activation of Cannabinoid CB2Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation

Nackley, A. G., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00886.2003 · Cited by 111 · see citing works

Chemotherapy-Induced Neuropathy

Cavaletti, G., Alberti, P., Frigeni, B., Piatti, M., & Susani, E. L. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0108-3 · Cited by 110 · see citing works

Cannabis and Its Derivatives: Review of Medical Use

Leung, L. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.04.100280 · Cited by 102 · see citing works

Chemotherapy-evoked Painful Peripheral Neuropathy

Polomano, R. C., & Bennett, G. J. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.002001008.x · Cited by 100 · see citing works

Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells

Burgos, E., Gómez‐Nicola, D., Pascual, D., Martı́n, M. I., Nieto‐Sampedro, M., & Goicoechea, C. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.02.008 · Cited by 99 · see citing works

Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels

Wilkerson, J. L., Gentry, K. R., Dengler, E. C., Wallace, J. A., Kerwin, A. A., Armijo, L. M., Kuhn, M. N., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2012) · Pain · doi:10.1016/j.pain.2012.02.015 · Cited by 99 · see citing works

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion

Nasser, M. W., Qamri, Z., Deol, Y. S., Smith, D. L., Shilo, K., Zou, X., & Ganju, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023901 · Cited by 96 · see citing works

Neurologic complications of cancer therapy

Plotkin, S. R., & Wen, P. Y. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00034-8 · Cited by 94 · see citing works

CXCR4 signaling mediates morphine-induced tactile hyperalgesia

Wilson, N. M., Jung, H., Ripsch, M. S., Miller, R. J., & White, F. A. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.014 · Cited by 94 · see citing works

Increased Chemokine Signaling in a Model of HIV1-Associated Peripheral Neuropathy

Bhangoo, S. K., Ripsch, M. S., Buchanan, D. J., Miller, R. J., & White, F. A. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-48 · Cited by 94 · see citing works

Cannabilactones: A Novel Class of CB2 Selective Agonists with Peripheral Analgesic Activity

Khanolkar, A. D., Lu, D., Ibrahim, M. M., Richard I. Duclos, Jr., Thakur, G. A., Malan, T. P., Porreca, F., Vijayabaskar, V., Tian, X., George, C. F., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070441u · Cited by 93 · see citing works

Domain-restricted expression of two glutamic acid decarboxylase genes in midgestation mouse embryos

Katarova, Z., Sekerkov�, G., Prodan, S., Mugnaini, E., & Szab�, G. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4 · Cited by 91 · see citing works

Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

Jhaveri, M. D., Sagar, D. R., Elmes, S. J. R., Kendall, D. A., & Chapman, V. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8007-7 · Cited by 89 · see citing works

MDA7: a novel selective agonist for CB₂ receptors that prevents allodynia in rat neuropathic pain models

Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82 · see citing works

Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain

Dubový, P., Klusáková, I., Svíženská, I. H., & Brázda, V. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0675-0 · Cited by 81 · see citing works

Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System

Naguib, M., Xu, J. J., Diaz, P., Brown, D. L., Cogdell, D. E., Bie, B., Hu, J., Craig, S. L., & Hittelman, W. N. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31824b0191 · Cited by 76 · see citing works

Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat

Carozzi, V., Chiorazzi, A., Canta, A., Lapidus, R. G., Slusher, B. S., Wozniak, K. M., & Cavaletti, G. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9114-1 · Cited by 67 · see citing works

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

Rahn, E. J., Thakur, G. A., Wood, J. A. T., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.024 · Cited by 57 · see citing works

Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats

Pascual, D., Goicoechea, C., Burgos, E., & Martín, M. I. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.009 · Cited by 52 · see citing works

Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain

Xu, J. J., Diaz, P., Astruc‐Diaz, F., Craig, S. L., Muñoz, E., & Naguib, M. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181e0cdaf · Cited by 51 · see citing works

First in Vivo Evidence for a Functional Interaction between Chemokine and Cannabinoid Systems in the Brain

Benamar, K., Geller, E. B., & Adler, M. W. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135053 · Cited by 30 · see citing works

Neurologic complications of cancer therapy

Uhm, J. H., & Yung, W. K. A. (1999) · Current Treatment Options in Neurology · doi:10.1007/s11940-996-0006-x · Cited by 28 · see citing works

Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain

Guindon, J., Desroches, J., Dani, M., & Beaulieu, P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.060 · Cited by 24 · see citing works

Physiological evidence for interaction between the HIV‐1 co‐receptor CXCR4 and the cannabinoid system in the brain

Benamar, K., Yondorf, M. Z., Geller, E. B., Eisenstein, T. K., & Adler, M. W. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00285.x · Cited by 23 · see citing works

Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. A study involving Walker 256 carcinosarcoma-bearing rats

Ye, S., Istfan, N. W., Driscoll, D. F., & Bistrian, B. R. (1992) · Cancer · doi:10.1002/1097-0142(19920101)69:1 · Cited by 19 · see citing works

A cannabinoid pharmacotherapy for chemotherapy-evoked painful peripheral neuropathy

Hohmann, A. G. (2005) · Pain · doi:10.1016/j.pain.2005.07.007 · Cited by 10 · see citing works

Untitled work

Elmquist (1998) · doi:10.1002/(sici)1096-9861(19980615)395:4

Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain

Sisignano, M., Baron, R., Scholich, K., & Geißlinger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.211 · Cited by 340 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐ HT1A receptors without diminishing nervous system function or chemotherapy efficacy

Ward, S. J., McAllister, S. D., Kawamura, R., Murase, R., Neelakantan, H., & Walker, E. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12439 · Cited by 277 · see citing works

Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)

Han, F. Y., & Smith, M. T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00156 · Cited by 273 · see citing works

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain

Lynch, M. E., Cesar-Rittenberg, P., & Hohmann, A. G. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.018 · Cited by 266 · see citing works

Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management

Vanderwall, A. G., & Milligan, E. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03009 · Cited by 219 · see citing works

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal

Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200 · see citing works

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

Fumagalli, G., Monza, L., Cavaletti, G., Rigolio, R., & Meregalli, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.626687 · Cited by 183 · see citing works

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment

Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160 · see citing works

Single and combined effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy‐induced neuropathic pain

King, K. M., Myers, A. M., Soroka‐Monzo, A. J., Tuma, R. F., Tallarida, R. J., Walker, E. A., & Ward, S. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13887 · Cited by 156 · see citing works

Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence

Slivicki, R. A., Xu, Z., Kulkarni, P. M., Pertwee, R. G., Mackie, K., Thakur, G. A., & Hohmann, A. G. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.032 · Cited by 136 · see citing works

Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice

Segat, G. C., Manjavachi, M. N., Matias, D. O., Passos, G. F., Freitas, C. S., da Costa, R., & Calixto, J. Β. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.015 · Cited by 113 · see citing works

Slowly Signaling G Protein–Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence

Lin, X., Dhopeshwarkar, A., Huibregtse, M. E., Mackie, K., & Hohmann, A. G. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109355 · Cited by 91 · see citing works

Opportunities for cannabis in supportive care in cancer

Kleckner, A., Kleckner, I., Kamen, C., Tejani, M., Janelsins, M., Morrow, G., & Peppone, L. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919866362 · Cited by 78 · see citing works

Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics–induced neuropathic pain

Xu, T., Zhang, X., Ouyang, H., Li, Z., Liu, C., Huang, Z., Xu, J., Wei, J., Nie, B., Ma, C., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000805 · Cited by 87 · see citing works

Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research

Leitzelar, B. N., & Koltyn, K. F. (2021) · Sports Medicine - Open · doi:10.1186/s40798-021-00307-9 · Cited by 84 · see citing works

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

Khasabova, I. A., Khasabov, S. G., Olson, J. K., Uhelski, M. L., Kim, A. H., Albino-Ramírez, A. M., Wagner, C. L., Seybold, V. S., & Simone, D. A. (2018) · Pain · doi:10.1097/j.pain.0000000000001448 · Cited by 72 · see citing works

Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain

Blanton, H. L., Brelsfoard, J., Deturk, N., Pruitt, K., Narasimhan, M., Morgan, D. J., & Guindon, J. (2019) · Drugs · doi:10.1007/s40265-019-01132-x · Cited by 70 · see citing works

Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal

Li, A.-L., Lin, X., Dhopeshwarkar, A., Thomaz, A. C., Carey, L. M., Liu, Y., Nikas, S. P., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113233 · Cited by 69 · see citing works

Prophylactic Cannabinoid Administration Blocks the Development of Paclitaxel-Induced Neuropathic Nociception during Analgesic Treatment and following Cessation of Drug Delivery

Rahn, E. J., Deng, L., Thakur, G. A., Vemuri, K. V., Zvonok, A. M., Lai, Y. Y., Makriyannis, A., & Hohmann, A. G. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-27 · Cited by 65 · see citing works

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

Kulkarni, P. M., Kulkarni, A., Korde, A., Tichkule, R. B., Laprairie, R. B., Denovan‐Wright, E. M., Zhou, H., Janero, D. R., Zvonok, N., Makriyannis, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01303 · Cited by 64 · see citing works

CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain

Deng, L., Cornett, B., Mackie, K., & Hohmann, A. G. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098483 · Cited by 60 · see citing works

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation

Mulpuri, Y., Marty, V. N., Munier, J. J., Mackie, K., Schmidt, B. L., Seltzman, H. H., & Spigelman, I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.002 · Cited by 62 · see citing works

2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective

Makriyannis, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500220s · Cited by 61 · see citing works

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence

Jiang, M., Huizenga, M. C. W., Wirt, J. L., Pálóczi, J., Amedi, A., van den Berg, R. J. B. H. N., Benz, J., Collin, L., Deng, H., Di, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43606-3 · Cited by 59 · see citing works

Paclitaxel Induces Acute Pain via Directly Activating Toll like Receptor 4

Yan, X., Maixner, D. W., Yadav, R., Gao, M., Li, P., Bartlett, M. G., & Weng, H. (2015) · Molecular Pain · doi:10.1186/s12990-015-0005-6 · Cited by 53 · see citing works

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 52 · see citing works

JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy

Khasabova, I. A., Yao, X., Paz, J., Lewandowski, C. T., Lindberg, A. E., Coicou, L., Burlakova, N., Simone, D. A., & Seybold, V. S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.09.008 · Cited by 50 · see citing works

The Complexity of Neuropathic Pain and Central Sensitization: Exploring Mechanisms and Therapeutic Prospects

Ma, Y.-C., Kang, Z.-B., Shi, Y., Ji, W.-Y., Zhou, W., & Wei, N. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2305089 · Cited by 47 · see citing works

Alterations in brain neurocircuitry following treatment with the chemotherapeutic agent paclitaxel in rats

Ferris, C. F., Nodine, S., Pottala, T., Cai, X., Knox, T. M., Fofana, F. H., Kim, S. J., Kulkarni, P. P., Crystal, J. D., & Hohmann, A. G. (2019) · Neurobiology of Pain · doi:10.1016/j.ynpai.2019.100034 · Cited by 47 · see citing works

Tempol Ameliorates and Prevents Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain

Kim, H. K., Hwang, S.-H., & Abdi, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00532 · Cited by 46 · see citing works

Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells

Jiang, L., Zhang, Q., Ren, H., Ma, S., Lu, C., Liu, B., Liu, J., Liang, J., Li, M., & Zhu, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124994 · Cited by 45 · see citing works

Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit

Slivicki, R. A., Saberi, S. A., Iyer, V., Vemuri, K. V., Makriyannis, A., & Hohmann, A. G. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252288 · Cited by 45 · see citing works

Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture

Pittman, S. K., Gracias, N. G., Vasko, M. R., & Fehrenbacher, J. C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.011 · Cited by 44 · see citing works

Neuro-immune interactions in paclitaxel-induced peripheral neuropathy

Vermeer, C. J. C., Hiensch, A. E., Cleenewerk, L., May, A. M., & Eijkelkamp, N. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1954241 · Cited by 39 · see citing works

Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe

Laprairie, R. B., Kulkarni, A., Kulkarni, P. M., Hurst, D. P., Lynch, D. L., Reggio, P. H., Janero, D. R., Pertwee, R. G., Stevenson, L., Kelly, M. E. M., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00041 · Cited by 39 · see citing works

CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain

Nent, E., Nozaki, C., Schmöle, A., Otte, D. M., & Zimmer, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-43858-4 · Cited by 37 · see citing works

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models

Masocha, W. (2018) · Pain Research and Management · doi:10.1155/2018/5234943 · Cited by 37 · see citing works

Small molecule inhibitors of PSD95–nNOS protein–protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats

Carey, L. M., Lee, W.-H., Gutierrez, T., Kulkarni, P. M., Thakur, G. A., Lai, Y. Y., & Hohmann, A. G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.055 · Cited by 33 · see citing works

A review of complementary therapies with medicinal plants for chemotherapy-induced peripheral neuropathy

Wu, B.-Y., Liu, C., Su, Y., Chen, S., Chen, Y., & Tsai, M.-Y. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.022 · Cited by 33 · see citing works

Corydalis saxicola Alkaloids Attenuate Cisplatin-Induced Neuropathic Pain by Reducing Loss of IENF and Blocking TRPV1 Activation

Kuai, C.-P., Ju, L., Hu, P.-P., & Huang, F. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500214 · Cited by 32 · see citing works

Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain

Pantouli, F., Grim, T. W., Schmid, C. L., Acevedo‐Canabal, A., Kennedy, N. M., Cameron, M. D., Bannister, T. D., & Bohn, L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108439 · Cited by 31 · see citing works

c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner

Henderson, A. N., Nealon, C. M., Davis, B. J., Yuill, M. B., Sepúlveda, D. E., Blanton, H. L., Piscura, M. K., Zee, M. L., Haskins, C. P., Marcus, D. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107847 · Cited by 32 · see citing works

The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory

Panoz‐Brown, D., Carey, L. M., Smith, A. E., Gentry, M., Sluka, C. M., Corbin, H. E., Wu, J.-E., Hohmann, A. G., & Crystal, J. D. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.08.001 · Cited by 30 · see citing works

Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain

Henderson, A. N., Crawford, L. C., Sepúlveda, D. E., Hale, D. E., Lesperance, J., & Morgan, D. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.684115 · Cited by 30 · see citing works

The CB2 cannabinoid receptor as a therapeutic target in the central nervous system

Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 29 · see citing works

Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy

Warren, W. G., Osborn, M., Tsantoulas, C., David-Pereira, A., Cohn, D., Duffy, P., Ruston, L., Johnson, C. T., Bradshaw, H. B., Kaczocha, M., et al. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.01.335 · Cited by 26 · see citing works

Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists

Dhopeshwarkar, A., Murataeva, N., Makriyannis, A., Straiker, A. J., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236539 · Cited by 26 · see citing works

Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches

Angelis, F. D., & Tata, A. M. (2016) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524916666160302103033 · Cited by 25 · see citing works

Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors

Parvathy, S. S., & Masocha, W. (2015) · Scientific Reports · doi:10.1038/srep10541 · Cited by 25 · see citing works

Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats

Alkislar, I., Miller, A. R., Hohmann, A. G., Sadaka, A. H., Cai, X., Kulkarni, P., & Ferris, C. F. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.11.015 · Cited by 24 · see citing works

Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests

Raup‐Konsavage, W. M., Sepúlveda, D. E., Wang, J., Dokholyan, N. V., Vrana, K. E., & Graziane, N. (2023) · Biomedicines · doi:10.3390/biomedicines12010083 · Cited by 24 · see citing works

Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems

Deng, L., Lee, W.-H., Xu, Z., Makriyannis, A., & Hohmann, A. G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.007 · Cited by 23 · see citing works

Effects of Taxol on Regeneration in a Rat Sciatic Nerve Transection Model

Hsu, S., Yao, C., Hsu, Y., Lin, J., Chen, Y., & Chen, Y.-S. (2017) · Scientific Reports · doi:10.1038/srep42280 · Cited by 23 · see citing works

Update on cannabis and cannabinoids for cancer pain

Chung, M. J., Kim, H. K., & Abdi, S. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000934 · Cited by 24 · see citing works

Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo

Slivicki, R. A., Ali, Y., Lu, H., & Hohmann, A. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147620 · Cited by 21 · see citing works

Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?

Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 20 · see citing works

Effect of Xylopic Acid on Paclitaxel-induced Neuropathic pain in rats

Ameyaw, E., Boampong, J., Kukuia, K. K. E., Amoateng, P., Obese, E., Osei-Sarpong, C., & Woode, E. (2014) · Journal of Medical and Biomedical Sciences · doi:10.4314/jmbs.v2i4.2 · Cited by 20 · see citing works

Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells

Yu, Z., Liu, T., Zhao, Y., Huang, Y., & Gao, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-1607-8 · Cited by 17 · see citing works

Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain

Wilkerson, J. L., Alberti, L. B., Kerwin, A. A., Ledent, C. A., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2020) · Brain and Behavior · doi:10.1002/brb3.1850 · Cited by 16 · see citing works

A hydro-ethanolic extract of Synedrella nodiflora (L.) Gaertn ameliorates hyperalgesia and allodynia in vincristine-induced neuropathic pain in rats

Amoateng, P., Adjei, S., Osei‐Safo, D., Ameyaw, E. O., Ahedor, B., N’guessan, B. B., & Nyarko, A. K. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2014-0084 · Cited by 16 · see citing works

Efficacy assessment of salicylidene salicylhydrazide in chemotherapy associated peripheral neuropathy

Rukh, L., Ali, G., Ullah, R., Islam, N. U., & Shahid, M. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173481 · Cited by 16 · see citing works

The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats

Guenther, K. G., Wirt, J. L., Oliva, I., Saberi, S. A., Crystal, J. D., & Hohmann, A. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110257 · Cited by 15 · see citing works

Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research

Ramer, R., & Hinz, B. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108851 · Cited by 15 · see citing works

β-Caryophyllene Inhibits Oxaliplatin-Induced Peripheral Neuropathy in Mice: Role of Cannabinoid Type 2 Receptors, Oxidative Stress and Neuroinflammation

Agnes, J. P., dos Santos, B., das Neves, R. N., Luciano, V. M. M., Benvenutti, L., Goldoni, F. C., Schran, R. G., Santin, J. R., Quintão, N. L. M., & Zanotto‐Filho, A. (2023) · Antioxidants · doi:10.3390/antiox12101893 · Cited by 14 · see citing works

Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy

Dönertaş, B., Ünel, Ç. Ç., & Erol, K. (2018) · Journal of Experimental Pharmacology · doi:10.2147/jep.s162059 · Cited by 14 · see citing works

Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca 2+ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy

Shannonhouse, J. L., Bernabucci, M., Gómez, R. S., Son, H., Zhang, Y., Ai, C.-H., Ishida, H., & Kim, Y. S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1064-21.2022 · Cited by 13 · see citing works

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential

Guenther, K. G., & Hohmann, A. G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70116 · Cited by 12 · see citing works

Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

Gorzo, A., Havasi, A. D., Spînu, Ș., Oprea, A. L., Burz, C. C., & Sur, D. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175036 · Cited by 13 · see citing works

Antiallodynic and anti-hyperalgesia effects ofTiliacora triandraagainst cisplatin-induced peripheral neuropathy

Liu, C., Ma, M., Wen, C., Zaman, R. U., & Olatunji, O. J. (2021) · All Life · doi:10.1080/26895293.2021.1927204 · Cited by 12 · see citing works

Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro

Campeau, L., Füllhase, C., Sawada, N., Gratzke, C., Hedlund, P., Howlett, A. C., & Andersson, K. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22454 · Cited by 9 · see citing works

2-Aminoethoxydiphenyl borate ameliorates functional and structural abnormalities in cisplatin-induced peripheral neuropathy

Eroglu, E., Ünel, Ç. Ç., HARMANCI, N., Erol, K., Arı, N. S., & Özatik, O. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126909 · Cited by 8 · see citing works

G Protein-Coupled Receptors and Ion Channels Involvement in Cisplatin-Induced Peripheral Neuropathy: A Review of Preclinical Studies

Becker, G., Atuati, S. F., & Oliveira, S. M. (2024) · Cancers · doi:10.3390/cancers16030580 · Cited by 8 · see citing works

Front and hind paw differential analgesic effects of amitriptyline, gabapentin, ibuprofen, and URB937 on mechanical and cold sensitivity in cisplatin-induced neuropathy

Thompson, J. M., Blanton, H. L., Pietrzak, A., Little, W., Sherfey, C., & Guindon, J. (2019) · Molecular Pain · doi:10.1177/1744806919874192 · Cited by 8 · see citing works

Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system

Kim, L., Nan, G., Kim, H. Y., Cha, M., & Lee, B. H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117515 · Cited by 7 · see citing works

Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats

Marino, C. D., Llorente‐Berzal, A., Diego, A. M., Bella, A., Boullon, L., Berrocoso, E., Roche, M., & Finn, D. P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1505980 · Cited by 7 · see citing works

Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat

Vera, G., López‐Gómez, L., Girón, R., Martı́n, M. I., Nurgali, K., Abalo, R., & Uranga, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914430 · Cited by 6 · see citing works

Centralizing the Knowledge and Interpretation of Pain in Chemotherapy-Induced Peripheral Neuropathy: A Paradigm Shift towards Brain-Centric Approaches

Cunha, M., Tavares, I., & Costa‐Pereira, J. T. (2024) · Brain Sciences · doi:10.3390/brainsci14070659 · Cited by 6 · see citing works

Evaluation of the Therapeutic Potential of Amantadine in a Vincristine-Induced Peripheral Neuropathy Model in Rats

Drummond, I. S. A., Oliveira, J. D. D., Niella, R. V., Silva, Á. J. C., de Oliveira, I. S., de Souza, S. S., Marques, C. S. D. C., Corrêa, J. M. X., Silva, J. F., & de Lavor, M. S. L. (2024) · Animals · doi:10.3390/ani14131941 · Cited by 6 · see citing works

ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models

Warren, W. G., Osborn, M., David-Pereira, A., Tsantoulas, C., Xue, W., Yates, A., & O’Sullivan, S. E. (2024) · European Journal of Pain · doi:10.1002/ejp.4718 · Cited by 5 · see citing works

Modulation of Pain by Endocannabinoids in the Periphery

Uhelski, M. L., Khasabova, I. A., & Simone, D. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79673 · Cited by 5 · see citing works

MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice

Cataldo, G., Lunzer, M. M., Akgün, E., Wong, H. L., Portoghese, P. S., & Simone, D. A. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.02.006 · Cited by 4 · see citing works

Attenuation of Streptozotocin-Induced Diabetic Neuropathic Allodynia by Flavone Derivative Through Modulation of GABA-ergic Mechanisms and Endogenous Biomarkers

Altaf, N., Rehman, N. U., Karim, N., Khan, I., Halim, S. A., Alotaibi, B. S., Hamad, R. S., Batiha, G. E., Tayyeb, J. Z., Turkistani, A. A., et al. (2024) · Neurochemical Research · doi:10.1007/s11064-023-04078-5 · Cited by 4 · see citing works

Involvement of selective GABA-A receptor subtypes in amelioration of cisplatin-induced neuropathic pain by 2’-chloro-6-methyl flavone (2’-Cl-6MF)

Karim, N., Khan, I., Abdelhalim, A., Halim, S. A., Khan, A., Altaf, N., Ahmad, W., Ghaffar, R., & Al‐Harrasi, A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02021-x · Cited by 3 · see citing works

Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists

Paton, K. F. (2018) · doi:10.26686/wgtn.17134067 · Cited by 1 · see citing works

Cannabinoids to Fight Chemotherapy-Induced Adverse Effects

Bagüés, A., Benítez, D., & Abalo, R. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_350-2 · Cited by 1 · see citing works

Muscarinic agonists in the treatment of neuropathic pain: a novel finding

Deng, L., & Guindon, J. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12123 · Cited by 1 · see citing works

MMG22 Potently Blocks Hyperalgesia in Cisplatin-Treated MicePreprint

Cataldo, G., Lunzer, M. M., Akgün, E., Wong, H. L., Portoghese, P. S., & Simone, D. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192510 · Cited by 1 · see citing works

Cannabinoids: clearing the smoke on pain, inflammation and neurodegeneration

Downer, E. J., & Finn, D. P. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12642

Helical Assemblies

Kurochkina, N. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-6601-7_5

Cannabinoids to Fight Chemotherapy-Induced Adverse Effects

Bagüés, A., Benítez, D., & Abalo, R. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_350-1

CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathyPreprint

Jesus, C. H. A., Reddy, G. R., Sizemore, E. F., Wirt, J. L., Sen, S., Yu, R. C., Takeuchi, T., Schwimmer, L. J., & Hohmann, A. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690750

Cannabinoids to Fight Chemotherapy-Induced Adverse Effects

Bagüés, A., Benítez, D., & Abalo, R. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_350

Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects

Zia, B., Meeran, M. F. N., Sharma, C., Mirza, S., & Ojha, S. K. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178646

BindingDB Entry 50006548: Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).

BindingDB (2020) · UC San Diego · doi:10.7270/q2z03c57

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., & Hohmann, A. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141994 · Cited by 116 · see citing works

A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse

Lin, X., Xu, Z., Carey, L. M., Romero, J., Makriyannis, A., Hillard, C. J., Ruggiero, E., Dockum, M., Houk, G., Mackie, K., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002502 · Cited by 36 · see citing works

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal

Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200 · see citing works

Prophylactic Cannabinoid Administration Blocks the Development of Paclitaxel-Induced Neuropathic Nociception during Analgesic Treatment and following Cessation of Drug Delivery

Rahn, E. J., Deng, L., Thakur, G. A., Vemuri, K. V., Zvonok, A. M., Lai, Y. Y., Makriyannis, A., & Hohmann, A. G. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-27 · Cited by 65 · see citing works

Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies

O’Hearn, S., Diaz, P. L., Wan, B. A., DeAngelis, C., Lao, N., Malek, L., Chow, E., & Blake, A. (2017) · Annals of Palliative Medicine · doi:10.21037/apm.2017.08.04 · Cited by 27 · see citing works